
Warning to millions of beachgoers over flesh-eating bacteria as victims suffer amputations
Their stories are a chilling warning as the fast-moving killer Vibrio vulnificus, a flesh-eating bacteria, becomes an increasing threat along America's beaches and shores, from the Gulf Coast to the Northeast.
Empson was enjoying a relaxed family vacation in Bay St Louis, Mississippi, in the summer of 2016 when his nightmare began.
After wading in warm waters for hours while fishing, the bacteria entered his body through microscopic breaks in his skin.
What started as a carefree afternoon ended with a frantic rush to intensive care. Doctors gave him a medication with just a 20 percent chance of working.
When it failed, they delivered a brutal ultimatum: lose his leg, or lose his life.
Meanwhile, Arceneaux has survived three separate brushes with Vibrio — twice from handling raw shellfish with open cuts on his hand and arm, and once from eating raw oysters.
In one instance, pain and swelling set in within two hours.
By the time he reached the hospital, blisters had formed and emergency surgery was underway to save his limbs.
He lived, but his arms now bear deep scars stretching to his shoulders.
Often contracted through small cuts or scrapes, Vibrio vulnificus hijacks the bloodstream and unleashes a cascade of flesh-destroying toxins.
It starves tissues of blood and oxygen, turning skin black and muscle into sludge.
If not caught in time, a minor wound can spiral into a life-threatening emergency — sometimes in less than 24 hours.
About 150 to 200 V. vulnificus infections are reported to the CDC each year and about one in five die.
The CDC has not issued an annual report on Vibrio in the U.S. since 2019, when 2,685 infections were recorded—but trends suggest cases are rising.
A sweeping review of CDC data from 1988 to 2018 revealed that Vibrio wound infections on the East Coast surged eightfold, from about 10 to over 80 cases per year.
Rising ocean temperatures are making colder regions like Alaska, the Baltic Sea, and Chile more hospitable to Vibrio, with scientists flagging them as potential hotspots. Paired with high seafood demand, coastal recreation, and climate change, experts warn of a sharp rise in infections—and deaths—in the near future.
When Empson got back to his family's beach house, he began experiencing early signs of vibriosis – swelling and pain in his foot, fever, chills, and blisters.
He tried to leave town to return to a hospital near his home in Baton Rouge, but he and his family realized they wouldn't make it. They went to a hospital near their stay in Waveland Beach, Mississippi.
'We got to the emergency room in Bay St. Louis, and when they found out we'd been at the beach, they were calling for a surgeon, and they immediately moved me into intensive care,' Empson told The Advocate.
Doctors then attempted to stop the infection in its tracks, but Empson was told the chance of it working was about 20 percent.
'I told him to take the leg, that I could learn to walk again,' he said.
His niece Angelle Daggett said: 'When he went in for surgery, his blood pressure [was so high] he should not have been alive.'
Empson spent weeks in rehabilitation therapy to relearn how to walk. He needs two canes to get around, do yard work, and fish.
These days, he does not wade into the water, staying on the bank instead.
Vibrio can enter the body through the smallest break in the skin, even a papercut.
It launches a rapid attack, releasing toxins that invade and kill tissues, disabling immune cells that rush to the body's defense, and invading the bloodstream, raising the odds of an infection leading to sepsis.
Within about 48 hours of exposure to the bacteria, toxic enzymes ravage tissue under the skin, liquifying muscle and fat, and leaving the skin blackened and rotten.
Arcenaux has been infected with the bacteria on two different occasions through cuts on his arms.
The first time he was infected, he got a small cut on his arm while about five dozen crabs, having reached into a water-filled bucket to lift one out one by one.
'That was on a Thursday, and within 24 hours I was on the way to the hospital and had surgery within two hours,' he said.
Arcenaux was able to avoid amputation. Doctors typically administer high doses of antibiotics intravenously and can sometimes halt the infection's spread by removing dead tissue on the arm.
'It was 36 hours at the Baton Rouge General for the next one, he said. 'To survive, I'm lucky twice, very lucky.
Vibrio requires warm water to grow and proliferate, making Gulf Coast beaches prime breeding grounds.
Louisiana Department of Health and Hospitals (LDHH) data indicates there are about 10 to 15 cases per year in the state and has not recorded any steady increases in recent years, though cases fluctate.
Most get the infection from skin contact with seawater (80 percent) or consumption of raw seafood (20 percent).
Laura Barajas, a 40-year-old mother from San Jose, underwent quadruple amputation after contracting a severe Vibrio vulnificus infection from undercooked tilapia she prepared at home in July.
The bacteria — which the CDC warns can cause life-threatening sepsis — left her in a medically induced coma with failing kidneys and necrotic limbs.
Barajas, who has a six-year-old son, survived but faces a lifelong disability. Her friend Anna Messina shared that Barajas' 'fingers were black, her feet were black her bottom lip was black' and her kidneys were failing as the infection ravaged her body.
'They put her into a medically induced coma,' Messina added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
8 minutes ago
- The Independent
Warning issued for common artificial sweetener that can interfere with cancer treatments
A popular sugar substitute may interfere with certain cancer treatments, according to new research. The University of Pittsburgh and UPMC Hillman Cancer Center have released new research suggesting that using sucralose — a popular sugar replacement used by those trying to lose weight or manage their blood sugar levels — may make it harder to the body to respond to certain cancer treatments. According to the research, patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose responded worse to immunotherapy and had worse survival rates than individuals whose diets had low levels of the artificial sweetener. The research also revealed a potential pathway for counteracting the potential negative effects of sucralose. The researchers found supplements that boost the levels of amino acid arginine actually counteracted the negative effects of the sweetener on immunotherapy treatments in mice. That approach could be pursed in further clinical trials to see if it can be used in humans. Doctor Abby Overacre, assistant professor in the Department of Immunology at the University of Pittsbugh and UPMC Hillman said in a statement that finding ways around forcing dietary changes is a worthwhile course of action, especially for cancer patients who are already dealing with the burden of the disease. 'It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,' she said. 'We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.' The study, which used testing on mice, found the negative effects were potentially caused by disruption to gut bacteria by the artificial sweetener. It found that sucralose caused a shift in the composition of the gut bacteria in mice which allowed for an increase in bacteria that degrade arginine. The increased arginine resulted in reduced levels of the amino acid in blood, tumor fluid, and stool. 'When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly,' Overacre said. 'As a result, immunotherapy wasn't as effective in mice that were fed sucralose.' Diwakar Davar, associate professor of medicine at the University of Pittsburgh and a medical oncologist and hematologist at UPMC Hillman, was a collaborator on the study and noted that the negative effects of sucralose was consistent across a range of treatments for a variety of cancer types and stages. He said that prebiotic supplements could theoretically be developed specifically for cancer patients with high levels of sucralose in their blood to help mitigate the negative effects. The researchers hope to pursue a clinical trial to determine whether or not boosting arginine through supplements will counteract the effects of the sucralose. They also plan to expand their research to look at the effects of other artificial sweeteners — such as aspartame, saccharin, xylitol, and stevia — on the immune system and on cancer treatments.


Reuters
8 minutes ago
- Reuters
Trump administration blocks funding for CDC health programs, WSJ reports
Aug 1 (Reuters) - U.S. President Donald Trump's administration is blocking funding for a swath of public-health programs run by the Centers for Disease Control and Prevention, the Wall Street Journal reported on Friday, citing unnamed sources. These include youth violence prevention programs, research on preventing gun injuries and deaths and efforts targeting diabetes, chronic kidney disease and tobacco use, according to the report. The money withheld could not be determined, but it could be as high as $200 million, the WSJ reported, citing a person familiar with the matter. The CDC did not immediately respond to a Reuters request for comment. The White House has previously stated its intention to reduce U.S. health spending by more than a quarter next year, with the National Institutes of Health and the Centers for Disease Control and Prevention facing the brunt of billions of dollars in cuts. Earlier this week, Susan Monarez was confirmed as CDC director to lead a downsized agency as the White House moves to slash its budget by nearly $3.6 billion, reducing it to about $4 billion. The cuts follow a layoff plan enacted by U.S. Health Secretary Robert F. Kennedy Jr. that eliminated 2,400 positions in CDC, though roughly 700 of those workers have since been rehired.


Daily Mail
39 minutes ago
- Daily Mail
Warning over common sweetener that could make cancer treatment less effective
A common artificial sweetener loved by millions weakens the effects of cancer treatments. University of Pittsburgh researchers discovered that sucralose, a zero-calorie sweetener, reduced immunotherapy effectiveness in melanoma and non-small cell lung cancer patients. Initially developed in the 1970s for people with obesity and diabetes to sweeten food while avoiding blood sugar spikes, sucralose, more commonly known as Splenda, has become ubiquitous. It's used in over 4,500 foods and drinks, including diet sodas and low-calorie foods. In the US, it accounts for 30 percent of the sweetener market. Cancer patients undergoing immunotherapy, which boosts the immune system to recognize and kill cancer cells, may reach for a diet soda or sugar-free baked good, believing they're making a healthy choice. However, sucralose kills some good bacteria that reside in the gut while allowing harmful strains to grow, impacting the body's ability to digest foods and break down fiber, train immune cells to fight pathogens, make vitamins like folate and B12, produce serotonin, and reduce inflammation. Senior author Dr Diwakar Davar, an oncologist and hematologist at UPMC, said in a statement: 'We found that sucralose impeded the effectiveness of immunotherapies across a range of cancer types, stages and treatment modalities. 'These observations raise the possibility of designing prebiotics, such as targeted nutrient supplementation for patients who consume high levels of sucralose.' The team used mouse models, some with lung cancer and some with melanoma, to test how sucralose altered their microbiomes, finding that the sweetener disrupted the delicate balance. This reduced key amino acids such as arginine, which are needed to fuel immune cells. It also led to dysfunctional CD8+ T cells, critical for fighting cancer, and blunted the effects of anti-PD-1 immunotherapy, a class of cancer treatments that includes popular medicines Keytruda and Opdivo. Lead author Dr Abby Overacre, an immunology professor at Pitt and UPMC Hillman, said: 'When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly. 'As a result, immunotherapy wasn't as effective in mice that were fed sucralose.' To assess the relevance of these findings for humans, they questioned 132 advanced cancer patients, including 91 people with melanoma and 41 with lung cancer, about their sucralose intake, as well as 25 people at high risk of their melanoma recurring. People reported drinking diet sodas, using the artificial sweetener in coffee and tea, and eating low-calorie snacks sweetened with it. A high amount of sucralose was considered anything above 0.16 mg per kilogram of body weight per day. For a 155-lb person, that's less than a single packet of Splenda. People with melanoma and lung cancer who consumed at least that much sucralose had a 3.2 times higher risk of their cancer progressing faster, as well as less tumor shrinkage in response to immunotherapy. People at risk of melanoma recurrence who drank or ate at least that much sucralose had a higher risk of their cancer returning after surgery and immunotherapy and fewer signs of a strong immune response to tumors. Experiments in mice revealed that disruption to the microbiome due to sucralose was the driving force behind alterations in their cancer-fighting T cells, which were starved of the crucial amino acid arginine. When scientists transplanted feces from sucralose-fed mice into untreated mice, the latter exhibited a similar poor immune response to immunotherapy. But when scientists supplemented their low levels of arginine using the amino acid citrulline, commonly found in melons, pumpkins, and legumes, T cells regained their cancer-killing ability, reversed their resistance to immunotherapy, and their tumors shrank. Their findings were published in the journal Cancer Discovery. Dr Overacre said: 'It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic. 'We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.' The researchers hope to launch a clinical trial investigating whether citrulline supplements, which boost arginine levels more than arginine itself, affect the gut microbiome and anti-tumor immune response in patients.